Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 6,434 shares at $16.81 ($108K) on 2018-11-06, disclosed to the SEC on 2018-11-08.
Open-market sale of $108k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.81 | 3,217 | $54K | 50.0% |
| 2 | $16.81 | 3,217 | $54K | 50.0% |
| Total | $16.81 avg | 6,434 | $108K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |